NCT04081584 is a clinical trial of ISS Device in Fetal Distress, sponsored by Raydiant Oximetry, Inc..

Who is sponsoring NCT04081584?

NCT04081584 is sponsored by Raydiant Oximetry, Inc..

What drugs are being tested in NCT04081584?

Interventions in NCT04081584: ISS Device.

What condition does NCT04081584 study?

NCT04081584 studies Fetal Distress.

Is NCT04081584 still recruiting?

NCT04081584 is currently terminated. Last updated 11 August 2021.

Last reviewed 2021-08-11 · How we verify

NCT04081584

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering

Terminated Last updated 11 August 2021

What this trial tests

trial testing ISS Device in Fetal Distress in 4 participants. Terminated before completion.

Timeline

1 July 2019

Primary endpoint
20 May 2021

8 June 2021

Quick facts

Lead sponsor	Raydiant Oximetry, Inc.
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	4
Start date	1 July 2019
Primary completion	20 May 2021
Estimated completion	8 June 2021
Sites	1 location across United States

Drugs / interventions tested

ISS Device

Conditions studied

Fetal Distress — all drugs for Fetal Distress →

Sponsor

Raydiant Oximetry, Inc.

Who can join

18 and older, female only, with Fetal Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being conducted to study light scattering properties of maternal-fetal tissue.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fetal Distress

Currently open trials in the same condition.

NCT07418151 — Effect of Maternal Chocolate Consumption on Fetal Non-Stress Test (NST) Reactivity. · NA · recruiting
NCT05681624 — Maternal Oxygen Supplementation for Intrauterine Resuscitation · NA · recruiting
NCT06186973 — Fetal Assessment of the Myocardium and Evaluation of the Neonate · recruiting

Other Raydiant Oximetry, Inc. trials

Trials by the same sponsor.

NCT06219538 — DAISY Uterine Drain Device Evaluation · NA · completed
NCT06405984 — Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE · EARLY_PHASE1 · completed
NCT05147584 — Trans-abdominal Fetal Pulse Oximetry · NA · terminated
NCT04876846 — Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity · NA · completed
NCT04081623 — Trans-abdominal Fetal Pulse Oximetry: Signal Integrity · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04081584 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Raydiant Oximetry, Inc.
Last refreshed: 11 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04081584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing